Normalized claim
Time: 10 seconds decrease
Reduced query time from about two minutes to 10 seconds.
CytoReason is an Israeli biotech and data platform that creates AI-based computational disease models using public and proprietary data. The company maps human diseases tissue by tissue and cell by cell to help pharma customers shorten clinical trials and reduce drug development costs. CytoReason moved PostgreSQL databases and analytics workloads to BigQuery to store and query very large datasets at speed. It also uses Google Kubernetes Engine for autoscaling and high-performance computing, and worked with WideOps to optimize Kubernetes infrastructure costs. The article says CytoReason built its own high-performance computing solution internally on GKE and uses Cloud Storage plus billing tools for cost optimization.
Reported outcomes
Time: Approximately 10 seconds
Time & speed
Normalized claim
Time: 10 seconds decrease
Reduced query time from about two minutes to 10 seconds.
No explicit deployment-stage evidence found.
Primary read
Showing 3 of 3
CytoReason migrated PostgreSQL data into BigQuery for faster analytics and query performance, and runs an internally built high-performance computing solution on Google Kubernetes Engine. The setup relies on GKE autoscaling and health checks, with Cloud Storage and billing tools used for cost optimization, and WideOps assisted with Kubernetes cost and infrastructure optimization.
AI-generated summary. Verify important details with the linked sources before relying on this case.
Was this useful?
Community
No published comments yet.